A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients
- 1 August 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Pain
- Vol. 93 (2) , 185-190
Abstract
A visual analog scale (VAS) method of assessing headache pain was compared with a standard categorical four-grade scale (4GS) in a randomized, placebo-controlled, double-blind, clinical trial involving 792 treated migraine outpatients who received oral rizatriptan 5 mg, sumatriptan 50 mg, or placebo for a moderate or severe headache. The VAS and 4GS were equally useful in demonstrating that the active drugs were superior to placebo at reducing headache pain, and in showing that the active drugs were similarly effective. For both rizatriptan and sumatriptan, slightly larger effect sizes were observed with the 4GS compared with the VAS. In analyses using data combined across all treatment groups, VAS and 4GS scores were highly correlated. Use of the VAS imposed additional administrative burdens. These findings suggest that the 4GS may be the preferred scale for assessing headache pain in clinical trials involving adult migraineurs.Keywords
This publication has 18 references indexed in Scilit:
- Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraineExpert Opinion on Investigational Drugs, 1999
- ZolmitriptanDrugs, 1999
- Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of MigraineHeadache: The Journal of Head and Face Pain, 1998
- Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in MigraineHeadache: The Journal of Head and Face Pain, 1998
- SumatriptanDrugs, 1998
- Response Measures in the Acute Treatment of MigraineCephalalgia, 1995
- Randomized, Placebo-Controlled Evaluation of Prochlorperazine Versus Metoclopramide for Emergency Department Treatment of Migraine HeadacheAnnals of Emergency Medicine, 1995
- Diclofenac-K (50 and 100 mg) and Placebo in the Acute Treatment of MigraineCephalalgia, 1993
- Methodology of Clinical Trials of Sumatriptan in Migraine and Cluster HeadacheEuropean Neurology, 1991
- Flunarizine (10 and 20 mg) i.v. Versus Placebo in the Treatment of Acute Migraine Attacks: A Multi-Centre Double-Blind StudyCephalalgia, 1990